• About us
    • About Lindahl
    • How we work
    • Said about Lindahl
    • Press
    • Find us
    • Privacy
  • Areas
    • Commercial dispute resolution
    • IT/Tech
    • Intellectual property
    • Life Sciences
    • M&A
    • All areas
  • Our people
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Helsingborg
    • Örebro
  • Latest news
    • Cases and transactions
    • News
    • Events
    • Knowledge
    • Portraits
  • Offices
    • Stockholm
    • Göteborg
    • Malmö
    • Uppsala
    • Örebro
    • Helsingborg

Lindahl advises in connection with PledPharma’s listing on Nasdaq Stockholm

  • Home
  • Latest news
  • Cases and transactions
  • 2019
  • Lindahl advises in connection with PledPharma’s listing on Nasdaq Stockholm

Lindahl was the legal advisor to PledPharma AB (publ) in connection with the company’s listing change from Nasdaq First North to Nasdaq Stockholm’s main market. Trading on Nasdaq Stockholm began on 31 October 2019.

PledPharma is a pharmaceutical drug development company that focuses on improving the treatment of serious medical conditions with a significant medical need. The company has two drug candidates in clinical development. PledOx® is a first-in-class drug candidate designed to prevent nerve damage associated with chemotherapy. A global Phase III programme is ongoing. Aladote® is a first-in-class drug candidate that is being developed to reduce acute liver damage caused by paracetamol poisoning. A proof-of-principle study, Phase Ib/IIa, has been successfully completed and the design of the next study is being completed. PledPharma’s head office is in Stockholm.

Lindahl’s team consisted of Gunnar Mattsson, Erika Svensson, Disa Almqvist, Helena Lindbäck and Therese Norenäs. A number of other employees also contributed to various parts of the project.

Contact

  • Gunnar Mattsson

    Uppsala

    gunnar.mattsson@lindahl.se +46 708 161 869
  • Erika Svensson

    Uppsala

    erika.svensson@lindahl.se +46 704 215 839
  • Disa Almqvist

    Uppsala

    disa.almqvist@lindahl.se +46 708 621 453
  • Helena Lindbäck

    Uppsala

    helena.lindback@lindahl.se +46 704 222 847
Pages
  • Start
  • About us
  • Areas
  • Our people
  • Latest news
  • Privacy
Our offices
  • Stockholm reception.stockholm@lindahl.se +46 8 527 70 800
  • Göteborg reception.goteborg@lindahl.se +46 31 799 10 00
  • Malmö reception.malmo@lindahl.se +46 40 664 66 50
  • Uppsala reception.uppsala@lindahl.se +46 18 16 18 50
  • Örebro reception.orebro@lindahl.se +46 19 20 89 00
  • Helsingborg reception.helsingborg@lindahl.se +46 42 17 53 00
Social media
  • Connect with us on social networks: Instagram, Linkedin, Youtube, Facebook,

Disclaimer

The material and information on this site is intended for general informational purposes only and does not constitute legal advice on any specific matter. Please note that all images on Lindahl's website, www.lindahl.se, are subject to intellectual property protection and downloading, publication, copying and/or other use of the images requires the written consent of the rights holder. You'll find Advokatfirman Lindahl KB's general terms and conditions here.

Some cookies are essential, others help us improve your experience by providing insights into how the site is used. For more information, please visit our Cookie Policy.

Essential Cookies

These cookies are necessary for the functionality of the site and cannot be disabled.

Analytics Cookies>

We use Analytics cookies to collect information that gives us insight into how our website is being used. We anonymize IP addresses in Google Analytics. By clicking on Decline we won't save theese cookies.

Decline
We use cookies to get insights on how our site is used and give our visitors the best possible experience